Skip to content

Joint Perfusion COVID-19 Task Force Webinar: Rationale and Practical use of CytoSorb

Rationale and Practical use of CytoSorb, an Extracorporeal Cytokine Adsorber, with ECMO to Treat Cytokine Storm in Critically-Ill COVID-19 patients

  • "CytoSorb and ECMO: A Novel "Lung Resting" Strategy in Critically-Ill COVID-19 patients under FDA Emergency Use Authorization"
    Dr. Phillip Chan, MD, PhD, CEO CytoSorbents Corporation
  • “Practical Experience in Treatment of COVID-19 Patients in Combination with ECMO and CytoSorb”
    Mr. Stefan Sajgo, Ulm University, Ulm Germany
Play Video

Share

|

Joint Perfusion COVID-19 Task Force Webinar: Rationale and Practical use of CytoSorb

Play Video

Share

|

Rationale and Practical use of CytoSorb, an Extracorporeal Cytokine Adsorber, with ECMO to Treat Cytokine Storm in Critically-Ill COVID-19 patients

  • "CytoSorb and ECMO: A Novel "Lung Resting" Strategy in Critically-Ill COVID-19 patients under FDA Emergency Use Authorization"
    Dr. Phillip Chan, MD, PhD, CEO CytoSorbents Corporation
  • “Practical Experience in Treatment of COVID-19 Patients in Combination with ECMO and CytoSorb”
    Mr. Stefan Sajgo, Ulm University, Ulm Germany

More Videos

Joint Perfusion COVID-19 Task Force Webinar 5: COVID-19 Treatment and Reopenings
Joint Perfusion COVID-19 Task Force Webinar 5: COVID-19 Treatment and Reopenings
Joint Perfusion COVID-19 Task Force: COVID-19 Patient Transport and Cytosorb Use
Joint Perfusion COVID-19 Task Force: COVID-19 Patient Transport and Cytosorb Use
Joint Perfusion COVID-19 Task Force: COVID-19 In Practice Third Webinar
Joint Perfusion COVID-19 Task Force: COVID-19 In Practice Third Webinar
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.